Nissay Asset Management Corp Japan ADV Has $8.70 Million Holdings in Colgate-Palmolive (CL)
Nissay Asset Management Corp Japan ADV lowered its position in shares of Colgate-Palmolive (NYSE:CL) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 126,919 shares of the company’s stock after selling 3,718 shares during the quarter. Nissay Asset Management Corp Japan ADV’s holdings in Colgate-Palmolive were worth $8,699,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently made changes to their positions in CL. Capital Financial Planning LLC purchased a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $27,000. Timber Creek Capital Management LLC increased its holdings in shares of Colgate-Palmolive by 247.1% in the 4th quarter. Timber Creek Capital Management LLC now owns 472 shares of the company’s stock valued at $28,000 after purchasing an additional 336 shares in the last quarter. Parisi Gray Wealth Management increased its holdings in shares of Colgate-Palmolive by 365.3% in the 4th quarter. Parisi Gray Wealth Management now owns 470 shares of the company’s stock valued at $28,000 after purchasing an additional 369 shares in the last quarter. Portfolio Solutions LLC purchased a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $30,000. Finally, WP Advisors LLC purchased a new position in shares of Colgate-Palmolive in the 1st quarter valued at about $34,000. Institutional investors own 75.95% of the company’s stock.
Colgate-Palmolive stock opened at $71.15 on Thursday. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $72.85. The stock has a market cap of $61.44 billion, a price-to-earnings ratio of 23.96, a PEG ratio of 4.69 and a beta of 0.81. The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.74 and a current ratio of 1.07.
The company also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th were paid a dividend of $0.43 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 annualized dividend and a dividend yield of 2.42%. The ex-dividend date of this dividend was Wednesday, April 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.91%.
In related news, Vice Chairman Dennis J. Hickey sold 6,060 shares of the firm’s stock in a transaction that occurred on Tuesday, February 19th. The shares were sold at an average price of $66.37, for a total value of $402,202.20. Following the sale, the insider now directly owns 407,294 shares of the company’s stock, valued at $27,032,102.78. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Stephen I. Sadove sold 8,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $71.55, for a total transaction of $572,400.00. Following the completion of the sale, the director now directly owns 39,441 shares in the company, valued at $2,822,003.55. The disclosure for this sale can be found here. Insiders have sold a total of 352,831 shares of company stock worth $24,752,192 over the last ninety days. 1.14% of the stock is owned by corporate insiders.
Several research firms have weighed in on CL. UBS Group raised their target price on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the company a “buy” rating in a report on Friday, March 29th. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $82.00 target price for the company in a report on Wednesday, May 1st. ValuEngine upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday. Morgan Stanley raised their target price on shares of Colgate-Palmolive from $62.00 to $68.00 and gave the company an “equal weight” rating in a report on Monday, April 29th. Finally, Macquarie set a $57.00 target price on shares of Colgate-Palmolive and gave the company a “hold” rating in a report on Tuesday, January 29th. One equities research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and five have assigned a buy rating to the company. Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $69.69.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Further Reading: Oversold
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.